GB2217596A - Anti-arthritic liposome composition - Google Patents
Anti-arthritic liposome composition Download PDFInfo
- Publication number
- GB2217596A GB2217596A GB8809803A GB8809803A GB2217596A GB 2217596 A GB2217596 A GB 2217596A GB 8809803 A GB8809803 A GB 8809803A GB 8809803 A GB8809803 A GB 8809803A GB 2217596 A GB2217596 A GB 2217596A
- Authority
- GB
- United Kingdom
- Prior art keywords
- bpaa
- lipid
- preparation according
- liposomal
- injection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8809803A GB2217596A (en) | 1988-04-26 | 1988-04-26 | Anti-arthritic liposome composition |
DE3912685A DE3912685A1 (de) | 1988-04-26 | 1989-04-18 | Pharazeutische praeparation, enthaltend felbinac |
JP1103589A JPH0211515A (ja) | 1988-04-26 | 1989-04-25 | フエルビナクを含有する製薬学的調製物 |
FR8905561A FR2630327A1 (fr) | 1988-04-26 | 1989-04-26 | Preparation liposomale d'acide 4-biphenylylacetique utile en therapie intra-articulaire |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8809803A GB2217596A (en) | 1988-04-26 | 1988-04-26 | Anti-arthritic liposome composition |
Publications (2)
Publication Number | Publication Date |
---|---|
GB8809803D0 GB8809803D0 (en) | 1988-06-02 |
GB2217596A true GB2217596A (en) | 1989-11-01 |
Family
ID=10635839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB8809803A Withdrawn GB2217596A (en) | 1988-04-26 | 1988-04-26 | Anti-arthritic liposome composition |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPH0211515A (fr) |
DE (1) | DE3912685A1 (fr) |
FR (1) | FR2630327A1 (fr) |
GB (1) | GB2217596A (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5411743A (en) * | 1990-12-03 | 1995-05-02 | Vestar, Inc. | Prevention of synovial adhesions |
WO2009147269A1 (fr) | 2008-06-06 | 2009-12-10 | Laboratorios Alcalá Farma, S.L. | Préparation topique d'ibuprofène |
CN104262138A (zh) * | 2014-08-22 | 2015-01-07 | 湖北美林药业有限公司 | 一种联苯乙酸化合物及其药物组合物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0249561A2 (fr) * | 1986-06-12 | 1987-12-16 | The Liposome Company, Inc. | Compositions utilisant des médicaments anti-inflammatoires non-stéroides encapsulés dans des liposomes |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1523965A (en) * | 1976-03-19 | 1978-09-06 | Ici Ltd | Pharmaceutical compositions containing steroids |
JPH0647533B2 (ja) * | 1984-08-10 | 1994-06-22 | 裕 水島 | 4−ビフエニリル酢酸系化合物含有脂肪乳剤 |
US4816247A (en) * | 1985-09-11 | 1989-03-28 | American Cyanamid Company | Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs |
-
1988
- 1988-04-26 GB GB8809803A patent/GB2217596A/en not_active Withdrawn
-
1989
- 1989-04-18 DE DE3912685A patent/DE3912685A1/de not_active Withdrawn
- 1989-04-25 JP JP1103589A patent/JPH0211515A/ja active Pending
- 1989-04-26 FR FR8905561A patent/FR2630327A1/fr not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0249561A2 (fr) * | 1986-06-12 | 1987-12-16 | The Liposome Company, Inc. | Compositions utilisant des médicaments anti-inflammatoires non-stéroides encapsulés dans des liposomes |
Non-Patent Citations (2)
Title |
---|
J Pharm Phar * |
Martindale,T * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5411743A (en) * | 1990-12-03 | 1995-05-02 | Vestar, Inc. | Prevention of synovial adhesions |
WO2009147269A1 (fr) | 2008-06-06 | 2009-12-10 | Laboratorios Alcalá Farma, S.L. | Préparation topique d'ibuprofène |
CN104262138A (zh) * | 2014-08-22 | 2015-01-07 | 湖北美林药业有限公司 | 一种联苯乙酸化合物及其药物组合物 |
CN104262138B (zh) * | 2014-08-22 | 2016-05-11 | 湖北美林药业有限公司 | 一种联苯乙酸化合物及其药物组合物 |
Also Published As
Publication number | Publication date |
---|---|
GB8809803D0 (en) | 1988-06-02 |
JPH0211515A (ja) | 1990-01-16 |
DE3912685A1 (de) | 1989-11-09 |
FR2630327A1 (fr) | 1989-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11839685B2 (en) | Composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same | |
US4844904A (en) | Liposome composition | |
KR100243921B1 (ko) | 규정된 지질계를 함유하는 제약조성물 | |
CA1339008C (fr) | Preparation liposomique d'amphotericine b | |
US4755388A (en) | Liposome-encapsulated 5-fluoropyrimidines and methods for their use | |
US5227165A (en) | Liposphere delivery systems for local anesthetics | |
JP3026271B2 (ja) | 活性薬剤の制御放出に用いる多小胞リポソームの調製 | |
KR970005171B1 (ko) | 아라키돈산 대사물질 관련 리포좀 제조방법 및 그 제제 | |
RU2493874C2 (ru) | Транслегочная липосома для регулирования доставки лекарственного средства | |
WO1990009782A1 (fr) | Composition liposomique sous forme de gel et son procede de preparation | |
KR20010023522A (ko) | 리포좀으로 캡슐화된 탁산의 투여방법 | |
Singh et al. | Liposomal ophthalmic drug delivery system. II. Dihydrostreptomycin sulfate | |
JPH11507628A (ja) | 改良されたリポソーム製剤 | |
US4963363A (en) | Phospholipid delivery vehicle for aqueous-insoluble active ingredients | |
Akbarieh et al. | Liposomal delivery system for the targeting and controlled release of praziquantel | |
JPH06507882A (ja) | 滑膜癒着の防止 | |
US5827532A (en) | Method for loading lipsomes with ionizable phosphorylated hydrophobic compounds, pharmaceutical preparations and a method for administering the preparations | |
GB2217596A (en) | Anti-arthritic liposome composition | |
PT97468B (pt) | Processo para a preparacao de suspensoes aquosas de lipossomas contendo em especial derivados iodados ou complexos de gadolinio | |
Foong et al. | Effect of liposomes on hamster oral mucosa | |
CN112773776B (zh) | 一种载药纳米粒体系 | |
JPWO2003015753A1 (ja) | リポソーム製剤 | |
WO1991006310A1 (fr) | Compositions liposomiques | |
Pandey et al. | Nanocarrier based transdermal formulation of NSAID: Optimization of drug loading and analysis of permeation characteristics | |
JPS63501569A (ja) | アルファトコフェロ−ルをベ−スとした小胞体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |